|Bid||83.98 x 900|
|Ask||84.07 x 900|
|Day's Range||83.17 - 84.50|
|52 Week Range||51.51 - 88.00|
|Beta (5Y Monthly)||0.92|
|PE Ratio (TTM)||66.44|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
If you are looking for the best ideas for your portfolio you may want to consider some of Wedgewood Partners top stock picks. Wedgewood Partners, an investment management firm, is bullish on Edwards Lifesciences Corp (NYSE:EW) stock. In its Q3 2019 investor letter – you can download a copy here – the firm discussed its […]
Boston Scientific recalled its Lotus Edge transcatheter heart-valve replacement system on Tuesday — sending BSX stock into a tailspin. The medical device gained FDA approval in 2019.
Does the November share price for Edwards Lifesciences Corporation (NYSE:EW) reflect what it's really worth? Today, we...